Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide/Formoterol vs Terbutaline for Moderate Asthma Exacerbation in Children
NCT04705727Phase 3Terminated
- Sponsor
- Centre Hospitalier Intercommunal de Créteil
- Start
- Aug 2021
- Primary completion
- Sep 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide + formoterol in asthma, sponsored by Centre Hospitalier Intercommunal de Créteil. Started Aug 2021; status: terminated.
02
Drugs
budesonide + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04705727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04705727.